Intrinsic factor Xase complex (Intrinsic Xase)

The intrinsic factor Xase complex is a multi-component enzymatic assembly essential for the propagation of the blood coagulation cascade (StatPearls, 2023). It is composed of the serine protease activated Factor IX (FIXa), the protein cofactor activated Factor VIII (FVIIIa), calcium ions, and a negatively charged phospholipid surface (PubMed, PMID: 21453365). The primary biological function of this complex is to catalyze the conversion of Factor X into its active form, Factor Xa, through specific proteolytic cleavage (UniProt, P00740). This step is significantly more efficient than the activation of Factor X by FIXa alone, increasing the reaction rate by several orders of magnitude (Journal of Biological Chemistry, 2003). Dysregulation or deficiency of the components within this complex results in significant clinical pathologies, most notably Hemophilia A and Hemophilia B (NIH, 2022). In these conditions, the inability to form a functional intrinsic Xase complex leads to impaired thrombin generation and severe bleeding tendencies. Modern therapeutic interventions target this complex by providing recombinant factor replacements or using innovative bispecific antibodies like emicizumab that mimic the cofactor activity of Factor VIII (FDA, 2017). Monitoring the activity of this complex is vital in managing patients with bleeding disorders and assessing the efficacy of bypass therapies or factor replacements (PubMed, PMID: 30168158).

Other names

Intrinsic tenase complexFactor IXa-Factor VIIIa complexFIXa-FVIIIa complexTenase complex

The complex catalyzes the conversion of zymogen Factor X to the active serine protease Factor Xa through limited proteolysis on a phospholipid surface (StatPearls, 2023).